Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by goldn1on Nov 17, 2019 2:18pm

76 Views

Post# 30361947

RE:RE:RE:RE:RE:RE:Expanded Access

China has a billion ppl, bur all TLT has is a patent in China, no approvals to test, enroll, etc. China has a similar process as the FDA, it used to be called the CFDA, but I believe there is a new name. Trying to start a trial in China will take years and resources away from the current goal. Once any Country sees a successful Phase II trial, think will be much easier. Below is a excerpt from the Chinese approval process, it is not as simple as some posters believe:

"Only 100 new drugs were approved between 2001 and 2016, about a third of the number in most Western countries. Approval times have been cut from six to seven years down to two or three years and data from overseas clinical trials is now accepted"

G1

Bullboard Posts

Geologica Resource: Polymetallic upside at a depressed price